Phibro Animal Health earnings were $31.8M for the trailing 12 months ending Mar 31, 2025, with 139.4% growth year over year. The latest PAHC earnings report on Mar 31, 2025 announced Q1 2025 earnings of $20.9M, up 555.6% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, PAHC reported annual earnings of $2.4M, with -92.6% growth.
PAHC past earnings growth
How has PAHC's earnings growth performed historically?
Phibro Animal Health Earnings Reports & History FAQ
What were Phibro Animal Health's earnings last quarter?
On PAHC's earnings call on Invalid Date, Phibro Animal Health (NASDAQ: PAHC) reported Q1 2025 earnings per share (EPS) of $0.52, up 147.62% year over year. Total PAHC earnings for the quarter were $20.88 million. In the same quarter last year, Phibro Animal Health's earnings per share (EPS) was $0.21.
Is Phibro Animal Health profitable or losing money?
As of the last Phibro Animal Health earnings report, Phibro Animal Health is currently profitable. Phibro Animal Health's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $31.79 million, a 141.54% increase year over year.
What was PAHC's earnings growth in the past year?
As of Phibro Animal Health's earnings date in Invalid Date, Phibro Animal Health's earnings has grown 139.39% year over year. This is 136.37 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 3.02%. PAHC earnings in the past year totalled $31.79 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.